InvestorsHub Logo
Followers 0
Posts 129
Boards Moderated 0
Alias Born 11/23/2011

Re: None

Monday, 01/02/2012 12:49:44 AM

Monday, January 02, 2012 12:49:44 AM

Post# of 867
Pfizer Inc.’s (NYSE:PFE) Prevnar 13 vaccine for a bacterial disease that results in pneumonia got acceptance for use in adults 50 and above, a range that may add nearly $2 billion to sales in 2015.

The Food and Drug Administration accepted the shot that would contend with Merck & Co. (NYSE:MRK)’s vaccine, which was accepted nearly 30 years back, the agency stated on Friday in a statement.

http://www.usamarketvoice.com/business-news/7766/pfizer-gets-green-signal-from-fda-on-prevnar-13.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News